Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD (Q35747040)
Jump to navigation
Jump to search
scientific article published on 3 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD |
scientific article published on 3 February 2012 |
Statements
1 reference
Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD (English)
1 reference
Dennis E Doherty
1 reference
Donald P Tashkin
1 reference
Edward Kerwin
1 reference
Barbara A Knorr
1 reference
Tulin Shekar
1 reference
Sibabrata Banerjee
1 reference
Heribert Staudinger
1 reference
3 February 2012
1 reference
7
1 reference
57-71
1 reference
1 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference